Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doug Coyle

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Cost Effectiveness and Resource Allocation : C/E|July 16, 2019
A technique for approximating transition rates from published survival analysesMarkian A Pahuta, Joel Werier, Eugene K Wai, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 6, 2008
Cost-effectiveness of cardiac rehabilitation program delivery models in patients at varying cardiac risk, reason for referral, and sexSophia Papadakis, Robert D Reid, Doug Coyle, et al.
Hospital Quarterly|July 9, 2003
Program evaluation of hospital-based antenatal home care for high-risk womenAnn Salvador, Barbara Davies, Karen Fung Fung, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 18, 2022
Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancerMiriam Kimpton, Srishti Kumar, Philip S Wells, et al.
Hearing Research|March 26, 2018
Auditory and language outcomes in children with unilateral hearing lossElizabeth M Fitzpatrick, Isabelle Gaboury, Andrée Durieux-Smith, et al.
The Journal of Rheumatology|April 3, 2003
OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritisSherine Gabriel, Michael Drummond, Andreas Maetzel, et al.
Pharmacoeconomics|May 15, 2020
Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility AnalysisJesse Elliott, Bláthnaid McCoy, Tammy Clifford, et al.
Journal of Oncology Practice|December 12, 2013
Cost effectiveness of a survivorship care plan for breast cancer survivorsDoug Coyle, Eva Grunfeld, Kathryn Coyle, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive StudyAnubhav Agarwal, Natasha Kekre, Harold Atkins, et al.
Systematic Reviews|October 1, 2014
A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXLStephen Brown, Brian Hutton, Tammy Clifford, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Cost Effectiveness and Resource Allocation : C/E|July 16, 2019
A technique for approximating transition rates from published survival analysesMarkian A Pahuta, Joel Werier, Eugene K Wai, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 6, 2008
Cost-effectiveness of cardiac rehabilitation program delivery models in patients at varying cardiac risk, reason for referral, and sexSophia Papadakis, Robert D Reid, Doug Coyle, et al.
Hospital Quarterly|July 9, 2003
Program evaluation of hospital-based antenatal home care for high-risk womenAnn Salvador, Barbara Davies, Karen Fung Fung, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 18, 2022
Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancerMiriam Kimpton, Srishti Kumar, Philip S Wells, et al.
Hearing Research|March 26, 2018
Auditory and language outcomes in children with unilateral hearing lossElizabeth M Fitzpatrick, Isabelle Gaboury, Andrée Durieux-Smith, et al.
The Journal of Rheumatology|April 3, 2003
OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritisSherine Gabriel, Michael Drummond, Andreas Maetzel, et al.
Pharmacoeconomics|May 15, 2020
Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility AnalysisJesse Elliott, Bláthnaid McCoy, Tammy Clifford, et al.
Journal of Oncology Practice|December 12, 2013
Cost effectiveness of a survivorship care plan for breast cancer survivorsDoug Coyle, Eva Grunfeld, Kathryn Coyle, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive StudyAnubhav Agarwal, Natasha Kekre, Harold Atkins, et al.
Systematic Reviews|October 1, 2014
A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXLStephen Brown, Brian Hutton, Tammy Clifford, et al.
Pageof 19